OSLO & BARCELONA, Spain--(BUSINESS WIRE)--DiaGenic ASA (OSE:DIAG) and Ferrer inCode today announced that they have signed a distribution agreement for the blood-based ADtect® test for early diagnosis of Alzheimer’s disease covering a total of 32 countries. The agreement gives Ferrer inCode, a biotech subsidiary of Grupo Ferrer Internacional, the exclusive right to sell and market ADtect® initially in Germany, Belgium, the Netherlands, Luxemburg, France, Italy, Spain and Portugal followed by Latin America.
